Interest and Amortization. (i) Interest at the Band Interest Rate shall accrue from date of advance until the Commencement Date; thereafter the Lakes Development Loan shall be payable as follows: monthly in arrears, beginning on the 15th day of the month after the month in which the Commencement Date occurs, in equal monthly payments of principal and interest for (a), if the term of the Lakes Development Loan is seven (7) years, the successive 84 months of the term; or (b) if the term of the Lakes Development Loan is five (5) years, in the successive 60 months of the term.
Interest and Amortization. Interest shall accrue at the rate of 13%. The amortization of the Lakes Facility Loan shall be the same as on the Lakes Development Loan.
Interest and Amortization. The loan will bear interest of 6% p.a. effective of the date of receipt of the loan. Amortization and interest will be redeemed as of June 30, 2007 at the latest. Sangui is entitled to redeem the loan either in cash or by providing shares of common stock, valued at 50% of the average Hamburg OTC trading price of Sangui’s stock over the four weeks preceding the redemption.
Interest and Amortization. (a) Interest shall accrue upon the outstanding principal balance of the Loan at the rate(s) provided in the Note, and such interest shall be payable as required therein.
Interest and Amortization. (i) The principal amount of the Tender Loans shall be repaid in full on the Termination Date.
Interest and Amortization. Interest or amortization on any loan or mortgage with respect to the Land or the Building.
Interest and Amortization. During the Interest Only Period, the Borrowers shall make payments of interest on each applicable Tranche in accordance with Clause 5.1.1 and Clause 6.1. After the Interest Only Period, the Borrowers shall make payments of principal and interest on each applicable Tranche in accordance with Clause 5.1.1. Notwithstanding the foregoing: A. if the Vadadustat FDA Approval is not received on or prior to June 30, 2024, the Interest Only Period will terminate on October 1, 2024, followed by 7 equal payments of principal and interest, which shall continue to accrue and become due and payable in accordance with the terms hereof (for the avoidance of doubt, the first 6 such payments shall be due on October 1, 2024 and each Monthly Payment Date thereafter through and including March 1, 2025, with the seventh and final such payment due on the Maturity Date); and B. if a Vadadustat Withdrawal Event occurs, the Borrowers shall repay, in advance, all principal and interest in respect of each Tranche in equal payments on (1) each of the twelve immediately succeeding Monthly Repayment Dates or (2) if less than twelve Monthly Repayment Dates remain before the Maturity Date, each such Monthly Repayment Date remaining before the Maturity Date, in each case commencing with the first Monthly Repayment Date to occur after the occurrence of such Vadadustat Withdrawal Event (as an illustrative example, if, after the occurrence of such Vadadustat Withdrawal Event, five Monthly Repayment Dates remain before the Maturity Date, the Borrowers shall repay all outstanding principal and interest in five equal payments: one on each such Monthly Repayment Date). Loan Term The Total Loan Facility will mature on March 31, 2025; provided, that if the Borrower Representative receives the Vadadustat FDA Approval on or prior to June 30, 2024, the maturity date will be automatically extended to January 29, 2028 (such applicable date, the “Maturity Date”). Transaction Fee Tranche A: [**]% of the aggregate committed amount in respect of Tranche A, payable upon the Closing Date. Tranche B: [**]% of the aggregate committed amount in respect of Tranche B, which shall be payable as follows: (a) on the Closing Date, [**]% of the aggregate committed amount in respect of Tranche B, and (b) [**]% of the aggregate committed amount in respect of Tranche B as of the Closing Date shall be payable on the earliest to occur of (i) the date Tranche B is funded, (ii) the date that the commitments in respect of Tranc...
Interest and Amortization. 10 6.08 Unused Loan Commitment Fee........................................................... 10 6.09 Expenses............................................................................. 10 6.10 Collateral; Release of Collateral.................................................... 11 6.11
Interest and Amortization. Postmedia Network Inc., a corporation incorporated under the Canada Business Corporations Act (the “Issuer”), promises to pay interest at a rate of 8.25% per annum payable in equal semi-annual payments and amortization equal to 5% per annum of the original principal amount of the Notes payable semi-annually in equal amounts of $6.25 million on both April 30th and October 31st of each year (or if such day is not a business day, the next following business day) (each a “Payment Date”), provided that the first Payment Date shall be April 30, 2013 and the interest and amortization payable shall be equal to $58.43 per $1,000 principal amount (in the case of interest) and $35.41 per $1,000 principal amount (in the case of amortization). Accordingly, due to the amortization of principal of this Note, any whole or partial redemptions or repurchases of this Note, and any increases or decreases (or exchanges) of interests in this Note, the outstanding principal amount of this Note at any time may be greater or less than the amount stated on the Front Side of this Note. The Issuer shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, at the rate equal to the then applicable interest rate on the Notes to the extent lawful and it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments or interest at the same rate to the extent lawful. Interest shall be computed on the basis of a 365-day or 366-day year, as applicable, and the actual number of elapsed days in that period. Interest shall accrue (in addition to the interest rate equal to the then applicable interest rate on the Notes) from and including the date on which an Event of Default under, Sections 6.01(a)(2), 6.01(a)(8) or 6.01(a)(9) of the Indenture shall occur to but excluding the date on which such Event of Default shall have been cured, at a rate per annum equal to 1.0% of the principal amount of the Notes.
Interest and Amortization. 10 6.08 ACM Report...................................................................................10 6.09 Expenses.....................................................................................10 6.10 Collateral; Release of Collateral............................................................11
